| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.013 | 0.8 |